Loading...
XNAS
ICUI
Market cap3.97bUSD
Jul 22, Last price  
157.44USD
1D
-0.84%
1Q
26.41%
Jan 2017
6.85%
Name

ICU Medical Inc

Chart & performance

D1W1MN
XNAS:ICUI chart
P/E
5,375.67
P/S
1.76
EPS
0.03
Div yield, %
Shrs. gr., 5y
2.90%
Rev. gr., 5y
11.90%
Revenues
2.23b
-6.38%
201,613,000188,138,000204,726,000231,513,000284,582,000302,195,000316,869,000313,716,000309,260,000341,668,000379,372,0001,292,613,0001,400,040,0001,266,208,0001,271,004,0001,316,308,0002,279,997,0002,259,126,0002,382,046,0002,230,025,000
Net income
732k
P
25,660,00023,079,00024,300,00026,557,00030,929,00044,669,00041,281,00040,418,00026,335,00044,985,00063,084,00068,644,00028,793,000101,035,00086,870,000103,135,000-74,286,000-29,655,000-117,688,000732,000
CFO
180m
-11.85%
31,608,00041,512,00030,227,00048,609,00033,095,00064,487,00066,271,00064,020,00060,640,00054,865,00089,941,000154,423,000160,215,000101,918,000222,752,000267,538,000-62,129,000166,201,000204,033,000179,847,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
IPO date
Mar 31, 1992
Employees
14,500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT